Mental Activity During (TMS) Therapy for Depression
Primary Purpose
Cognitive Impairment
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
TMS and Lumosity®cognitive retraining
TMS and non cognitive computer games
Sponsored by

About this trial
This is an interventional treatment trial for Cognitive Impairment focused on measuring Depression, Transcranial Magnetic Stimulation (TMS)
Eligibility Criteria
Inclusion Criteria:
• Subject has a diagnosis of depression
- Subject has been approved and scheduled to receive TMS at Augusta University
- Subject does not have a major neurocognitive impairment or an alcohol or substance abuse disorder, and can see images on a computer monitor.
Exclusion Criteria:
-
Sites / Locations
- Augusta University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
TMS and Lumosity® cognitive retraining
TMS and non cognitive computer games
Arm Description
Group will receive TMS and will concurrently engage in cognitive retraining exercises comprised of the Lumosity® battery.
Group will receive TMS while concurrently engaging in selected computer games from several gaming software that includes Play 101 Games and Hoyle Puzzle and Board Games®. They will also be allowed to spend time on gaming activities of their choice in order to keep them engaged
Outcomes
Primary Outcome Measures
The University of Pennsylvania Computerized Neuropsychological Testing Battery (Penn CNP)
Administers computerized neuropsychological tests for research studies
Secondary Outcome Measures
The Lumosity® Brain Performance Test (BPT)
Online neuropsychological battery of assessments measuring training-related changes in Cognitive Performance
Inventory of Depressive Symptoms- Self Report
Patient rating of depressive symptom severity
Hamilton Depression Rating Scale 17 item
Clinician Rating of Depressive Symptoms
Full Information
NCT ID
NCT03701932
First Posted
March 26, 2018
Last Updated
August 27, 2020
Sponsor
Augusta University
Collaborators
Lumos Labs, Inc.
1. Study Identification
Unique Protocol Identification Number
NCT03701932
Brief Title
Mental Activity During (TMS) Therapy for Depression
Official Title
Mental Activity During Transcranial Magnetic Stimulation (TMS) Therapy for Depression
Study Type
Interventional
2. Study Status
Record Verification Date
August 2020
Overall Recruitment Status
Completed
Study Start Date
March 6, 2015 (Actual)
Primary Completion Date
July 31, 2019 (Actual)
Study Completion Date
July 31, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Augusta University
Collaborators
Lumos Labs, Inc.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of the study is to assess the effects of different types of mental activity performed while receiving transcranial magnetic stimulation (TMS) for the treatment of major depressive disorder. Our primary aim for this study is to assess the feasibility of combining TMS and computer based cognitive exercise in patients with major depressive disorder who may also have some degree of cognitive dysfunction, and to formally measure changes in mood and cognition over the course of the study.
Detailed Description
Patients will receive TMS treatment daily for 6 weeks as part of their standard care. They will complete clinical assessments and participate in cognitive retraining through completion of 15 hours of Lumosity gaming cognitive exercises while simultaneously receiving active TMS stimulation. Those participants in the control group will complete 15 hours of computer gaming activity during the administration of active stimulation. Computer games in the control group exercises are elected by the patient from a library of intellectually and motivationally engaging games drawn from several gaming software compilations that includes Play 101 Games and Hoyle Puzzle and Board Games.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cognitive Impairment
Keywords
Depression, Transcranial Magnetic Stimulation (TMS)
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
11 (Actual)
8. Arms, Groups, and Interventions
Arm Title
TMS and Lumosity® cognitive retraining
Arm Type
Experimental
Arm Description
Group will receive TMS and will concurrently engage in cognitive retraining exercises comprised of the Lumosity® battery.
Arm Title
TMS and non cognitive computer games
Arm Type
Active Comparator
Arm Description
Group will receive TMS while concurrently engaging in selected computer games from several gaming software that includes Play 101 Games and Hoyle Puzzle and Board Games®. They will also be allowed to spend time on gaming activities of their choice in order to keep them engaged
Intervention Type
Behavioral
Intervention Name(s)
TMS and Lumosity®cognitive retraining
Intervention Description
The Lumosity® training includes exercises for speed, memory, attention, flexibility, and problem solving. Subjects will complete this battery while receiving TMS treatment.
Intervention Type
Behavioral
Intervention Name(s)
TMS and non cognitive computer games
Intervention Description
Subjects will play computer games while receiving TMS treatment.
Primary Outcome Measure Information:
Title
The University of Pennsylvania Computerized Neuropsychological Testing Battery (Penn CNP)
Description
Administers computerized neuropsychological tests for research studies
Time Frame
Change from baseline at six weeks
Secondary Outcome Measure Information:
Title
The Lumosity® Brain Performance Test (BPT)
Description
Online neuropsychological battery of assessments measuring training-related changes in Cognitive Performance
Time Frame
Change from baseline at six weeks
Title
Inventory of Depressive Symptoms- Self Report
Description
Patient rating of depressive symptom severity
Time Frame
Change from baseline at six weeks
Title
Hamilton Depression Rating Scale 17 item
Description
Clinician Rating of Depressive Symptoms
Time Frame
Change from baseline at six weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
• Subject has a diagnosis of depression
Subject has been approved and scheduled to receive TMS at Augusta University
Subject does not have a major neurocognitive impairment or an alcohol or substance abuse disorder, and can see images on a computer monitor.
Exclusion Criteria:
-
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter B Rosenquist, MD
Organizational Affiliation
Augusta University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Augusta University
City
Augusta
State/Province
Georgia
ZIP/Postal Code
30912
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Mental Activity During (TMS) Therapy for Depression
We'll reach out to this number within 24 hrs